PBM strikes back at FTC over drug pricing report
The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of the report, which the company claims is "unfair, biased, erroneous, and defamatory" against the PBM industry and is "seventy-four pages of unsupported innuendo."
Express Scripts files suit against FTC, demands retraction of report on PBM industry These PBMs value high rebates from ...
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the ...
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade Commission and ...
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on ...
As the FTC has increasingly prodded PBMs over their role in high drug costs, Express Scripts is fighting back by launching a ...
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback